ArticleBMC cancer2024

The VALTIVE1 study protocol: a study for the validation of Tie2 as the first tumour vascular response biomarker for VEGF inhibitors.

Margherita Carucci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.